Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Antithrombotic therapy in cerebral infarction].

N Tanahashi1

  • 1Department of Neurology, School of Medicine, Keio University, Tokyo, Japan.

Rinsho Shinkeigaku = Clinical Neurology
|July 24, 2001
PubMed
Summary

Antithrombotic therapies for acute cerebral infarction include thrombolysis, anticoagulants, and antiplatelets. Treatment choice depends on lesion type, time, and severity, with aspirin showing slight efficacy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transient ischemic attack without self-awareness of symptoms witnessed by bystanders: analysis of the PROMISE-TIA registry.

European journal of neurology·2020
Same author

Spin structure and spin Hall magnetoresistance of epitaxial thin films of the insulating non-collinear antiferromagnet SmFeO<sub>3</sub>.

Journal of physics. Condensed matter : an Institute of Physics journal·2019
Same author

Differences in erythrocyte aggregability between multi-infarct dementia and Alzheimer's disease.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2015
Same author

Features of cardioembolic stroke with persistent and paroxysmal atrial fibrillation - a study with the Japan Stroke Registry.

European journal of neurology·2015
Same author

Dysgraphia due to anterior choroidal artery territory infarction: a case report.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2013
Same author

Functional outcome in patients with pontine infarction after acute rehabilitation.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2011

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Pharmacology

Context:

  • Cerebral infarction, or stroke, necessitates timely antithrombotic interventions.
  • Current acute-stage treatments involve thrombolysis, anticoagulation, and antiplatelet agents.
  • Treatment selection is guided by clinicopathological factors, onset time, and illness severity.

Purpose:

  • To review current antithrombotic therapies for acute cerebral infarction.
  • To discuss the efficacy and limitations of various antithrombotic agents.
  • To outline strategies for stroke recurrence prevention in the chronic stage.

Summary:

  • Tissue plasminogen activator is approved for use within 3 hours of stroke onset in the US.
  • Heparin's efficacy in acute cerebral infarction is unproven due to hemorrhagic risks.
  • Argatroban (selective thrombin inhibitor) and sodium ozagrel (thromboxane A2 synthetase inhibitor) are used in Japan.
  • Low-dose aspirin demonstrates modest efficacy in the acute phase.
  • Chronic-stage prevention involves antiplatelet therapy (aspirin, ticlopidine) for atherothrombotic stroke and warfarin for cardioembolic stroke.

Impact:

  • Provides a comprehensive overview of antithrombotic strategies for cerebral infarction.
  • Highlights the importance of tailored treatment based on stroke subtype and timing.
  • Informs clinical decision-making for acute stroke management and secondary prevention.

Related Experiment Videos